NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice

European Journal of Immunology

Volumn 44, Issue 6, 2014, Pages 1802-1813

  Lee, Jung Eun ^a,e   Lim, Seon Ah ^a   Kim, Tae Jin ^a,d   Kim, Kwanghee ^a   Ng, Joanne ^a   Kim, Yong Ho ^b   Jang, In Jung ^b   Oh, Seog Bae ^b   Lee, June Chul ^f   Yee, Cassian ^c   Kumar, Vinay ^d   Lee, Kyung Mi ^a  

^a Korea University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e Korea University   (South Korea)

^f Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

2B4; Natural killer cells; NKG2D; Self tolerance

Indexed keywords

CD48 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN; PROTEIN 2B4; PROTEIN RAE 1GAMMA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; TUMOR REGRESSION;

2B4; NATURAL KILLER CELLS; NKG2D; SELF-TOLERANCE;

ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; FEMALE; IMMUNOLOGIC CAPPING; KILLER CELLS, NATURAL; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NEOPLASMS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RECEPTORS, IMMUNOLOGIC; SELF TOLERANCE; TUMOR MICROENVIRONMENT;

EID: 84899583510     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343724     Document Type: Article

References (32)

1. Vivier, E., Ugolini, S., Blaise, D., Chabannon, C. and Brossay, L., Targeting natural killer cells and natural killer T cells in cancer. Nat. Rev. Immunol. 2012. 12: 239-252.
2. Raulet, D. H., Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 2003. 3: 781-790.
3. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L. and Spies, T., Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999. 285: 727-729.
4. Gonzalez, S., Lopez-Soto, A., Suarez-Alvarez, B., Lopez-Vazquez, A. and Lopez-Larrea, C., NKG2D ligands: key targets of the immune response. Trends Immunol. 2008. 29: 397-403.
5. Lanier, L. L., NK cell receptors. Annu. Rev. Immunol. 1998. 16: 359-393.
6. McNerney, M. E., Guzior, D. and Kumar, V., 2B4 (CD244)-CD48 interactions provide a novel MHC class I-independent system for NK-cell self-tolerance in mice. Blood 2005. 106: 1337-1340.
7. Latchman, Y., McKay, P. F. and Reiser, H., Identification of the 2B4 molecule as a counter-receptor for CD48. J. Immunol. 1998. 161: 5809-5812.
8. Brown, M. H., Boles, K., van der Merwe, P. A., Kumar, V., Mathew, P. A. and Barclay, A. N., 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med. 1998. 188: 2083-2090.
9. Lee, K. M., McNerney, M. E., Stepp, S. E., Mathew, P. A., Schatzle, J. D., Bennett, M. and Kumar, V., 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J. Exp. Med. 2004. 199: 1245-1254.
10. Sinha, S. K., Gao, N., Guo, Y. and Yuan, D., Mechanism of induction of NK activation by 2B4 (CD244) via its cognate ligand. J. Immunol. 2010. 185: 5205-5210.
11. Costello, R. T., Sivori, S., Marcenaro, E., Lafage-Pochitaloff, M., Mozziconacci, M. J., Reviron, D., Gastaut, J. A., Pende, D., Olive, D. and Moretta, A., Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 2002. 99: 3661-3667.
12. Waggoner, S. N., Taniguchi, R. T., Mathew, P. A., Kumar, V. and Welsh, R. M., Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis. J. Clin. Invest. 2010. 120: 1925-1938.
13. Vaidya, S. V., Stepp, S. E., McNerney, M. E., Lee, J. K., Bennett, M., Lee, K. M., Stewart, C. L., Kumar, V. and Mathew, P. A., Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells. J. Immunol. 2005. 174: 800-807.
14. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R. and Moretta, L., Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 2001. 19: 197-223.
15. Lodoen, M., Ogasawara, K., Hamerman, J. A., Arase, H., Houchins, J. P., Mocarski, E. S. and Lanier, L. L., NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 2003. 197: 1245-1253.
16. Cerwenka, A., Baron, J. L. and Lanier, L. L., Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. U. S. A. 2001. 98: 11521-11526.
17. Sun, C., Fu, B., Gao, Y., Liao, X., Sun, R., Tian, Z. and Wei, H., TGF-beta1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog. 2012. 8: e1002594.
18. Lee, J. C., Lee, K. M., Kim, D. W. and Heo, D. S., Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J. Immunol. 2004. 172: 7335-7340.
19. Crane, C. A., Han, S. J., Barry, J. J., Ahn, B. J., Lanier, L. L. and Parsa, A. T., TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. Neuro. Oncol. 2010. 12: 7-13.
20. Oppenheim, D. E., Roberts, S. J., Clarke, S. L., Filler, R., Lewis, J. M., Tigelaar, R. E., Girardi, M. and Hayday, A. C., Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat. Immunol. 2005. 6: 928-937.
21. Lee, K. M., Forman, J. P., McNerney, M. E., Stepp, S., Kuppireddi, S., Guzior, D., Latchman, Y. E., Sayegh, M. H., Yagita, H., Park, C. K., Oh, S. B., Wulfing, C., Schatzle, J., Mathew, P. A., Sharpe, A. H. and Kumar, V., Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions. Blood 2006. 107: 3181-3188.
22. Taniguchi, R. T., Guzior, D. and Kumar, V., 2B4 inhibits NK-cell fratricide. Blood 2007. 110: 2020-2023.
23. Kim, E. O., Kim, T. J., Kim, N., Kim, S. T., Kumar, V. and Lee, K. M., Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2. J. Biol. Chem. 2010. 285: 41755-41764.
24. Valiante, N. M. and Trinchieri, G., Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J. Exp. Med. 1993. 178: 1397-1406.
25. Tangye, S. G., Lazetic, S., Woollatt, E., Sutherland, G. R., Lanier, L. L. and Phillips, J. H., Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol. 1999. 162: 6981-6985.
26. Nakajima, H., Cella, M., Langen, H., Friedlein, A. and Colonna, M., Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur. J. Immunol. 1999. 29: 1676-1683.
27. Dupre, L., Andolfi, G., Tangye, S. G., Clementi, R., Locatelli, F., Arico, M., Aiuti, A. and Roncarolo, M. G., SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. Blood 2005. 105: 4383-4389.
28. Vaidya, S. V. and Mathew, P. A., Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells. Immunol. Lett. 2006. 105: 180-184.
29. Chlewicki, L. K., Velikovsky, C. A., Balakrishnan, V., Mariuzza, R. A. and Kumar, V., Molecular basis of the dual functions of 2B4 (CD244). J. Immunol. 2008. 180: 8159-8167.
30. Fortenbery, N. R., Paraiso, K. H., Taniguchi, M., Brooks, C., Ibrahim, L. and Kerr, W. G., SHIP influences signals from CD48 and MHC class I ligands that regulate NK cell homeostasis, effector function, and repertoire formation. J. Immunol. 2010. 184: 5065-5074.
31. Lee, K. M., Bhawan, S., Majima, T., Wei, H., Nishimura, M. I., Yagita, H. and Kumar, V., Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells. J. Immunol. 2003. 170: 4881-4885.
32. Yoon, S. H., Yun, S. O., Park, J. Y., Won, H. Y., Kim, E. K., Sohn, H. J., Cho, H. I. and Kim, T. G., Selective addition of CXCR3(+) CCR4(-) CD4(+) Th1 cells enhances generation of cytotoxic T cells by dendritic cells in vitro. Exp. Mol. Med. 2009. 41: 161-170.